We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.8B
AUM Growth
-$180M
Cap. Flow
-$262M
Cap. Flow %
-6.89%
Top 10 Hldgs %
17.53%
Holding
781
New
342
Increased
77
Reduced
104
Closed
239

Top Buys

Rank Stock Value
1
HON icon
Honeywell
HON
+$71.1M
2
ARMK icon
Aramark
ARMK
+$57.7M
3
BA icon
Boeing
BA
+$46.8M
4
EBAY icon
eBay
EBAY
+$46.2M
5
ITGR icon
Integer Holdings
ITGR
+$41.2M

Sector Composition

Rank Sector Weight
1 Industrials 14.07%
2 Consumer Discretionary 12.1%
3 Technology 10.49%
4 Healthcare 7.89%
5 Financials 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DKNG icon
126
DraftKings
DKNG
$11.6B
$8.32M 0.22%
241,571
+234,054
+3,114% +$7.7M
MRVL icon
127
Marvell Technology
MRVL
$168B
$8.29M 0.22%
+97,499
New +$8.53M
TERN
128
DELISTED
Terns Pharmaceuticals
TERN
$8.21M 0.22%
+203,192
New +$4.7M
DELL icon
129
CALL
Dell
DELL
$262B
$8.18M 0.22%
+65,000
New +$9.16M
MAGN
130
Magnera Corp
MAGN
$472M
$8.15M 0.21%
538,220
+99,523
+23% +$1.15M
AVGO icon
131
Broadcom
AVGO
$1.85T
$8.09M 0.21%
23,377
-93,964
-80% -$33.6M
EQT icon
132
CALL
EQT Corp
EQT
$33.3B
$8.04M 0.21%
+150,000
New +$8.43M
CAPR icon
133
CALL
Capricor Therapeutics
CAPR
$223M
$8.02M 0.21%
277,900
+142,900
+106% +$1.87M
NIQ
134
NIQ Global Intelligence PLC
NIQ
$3.3B
$7.91M 0.21%
+479,590
New +$7.02M
KRSP
135
Rice Acquisition Corporation 3
KRSP
$484M
$7.84M 0.21%
+765,000
New +$7.93M
ANSC
136
Agriculture & Natural Solutions Acquisition Corp
ANSC
$476M
$7.83M 0.21%
+700,000
New +$7.76M
JPM icon
137
CALL
JPMorgan Chase
JPM
$935B
$7.83M 0.21%
+24,300
New +$7.52M
MAT icon
138
CALL
Mattel
MAT
$4.38B
$7.81M 0.21%
+393,800
New +$7.61M
WULF icon
139
CALL
TeraWulf
WULF
$8.75B
$7.8M 0.21%
+679,000
New +$9.1M
DINO icon
140
HF Sinclair
DINO
$16.3B
$7.75M 0.2%
+168,200
New +$8.67M
REGN icon
141
CALL
Regeneron Pharmaceuticals
REGN
$78.5B
$7.72M 0.2%
10,000
+2,000
+25% +$1.36M
REGN icon
142
PUT
Regeneron Pharmaceuticals
REGN
$78.5B
$7.72M 0.2%
10,000
RIVN icon
143
Rivian
RIVN
$22B
$7.59M 0.2%
+385,238
New +$6.12M
NBIX icon
144
Neurocrine Biosciences
NBIX
$16.8B
$7.56M 0.2%
53,303
+6,375
+14% +$924K
GME icon
145
CALL
GameStop
GME
$9.75B
$7.43M 0.2%
+370,200
New +$8.31M
VSTM icon
146
Verastem
VSTM
$510M
$7.31M 0.19%
947,303
+533,431
+129% +$4.75M
ACVA icon
147
CALL
ACV Auctions
ACVA
$1.31B
$7.25M 0.19%
903,800
+233,800
+35% +$1.89M
APLS
148
DELISTED
Apellis Pharmaceuticals
APLS
$7.18M 0.19%
285,992
+2,839
+1% +$66.6K
RKT icon
149
CALL
Rocket Companies
RKT
$36.5B
$7.18M 0.19%
370,900
-569,100
-61% -$10.2M
CCII
150
Cohen Circle Acquisition Corp II
CCII
$359M
$7.05M 0.19%
688,046
+124,295
+22% +$1.28M

Similar funds

J. Goldman & Co's Q4 2025 Portfolio in Review

As of Q4 2025, J. Goldman & Co held 781 positions worth $3.8B, down 4.5% from $3.98B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

J. Goldman & Co withdrew a net $262M in Q4 2025, closing 239 positions and reducing 104 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $74.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, J. Goldman & Co opened a new position in Honeywell worth $70.9M.

  • J. Goldman & Co's largest Q4 2025 buy was Honeywell: 363,411 shares worth $70.9M.
  • J. Goldman & Co added most to eBay in Q4 2025, an estimated $46.2M increase.
  • J. Goldman & Co's biggest Q4 2025 reduction was Globus Medical, cutting an estimated $61.8M.
  • J. Goldman & Co fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $74.4M.
  • J. Goldman & Co's ten largest holdings make up 18% of its $3.8B portfolio in Q4 2025.
  • J. Goldman & Co opened 342 new positions and closed 239 in Q4 2025.
  • J. Goldman & Co's portfolio value fell 4.5% quarter-over-quarter to $3.8B.

Based on J. Goldman & Co's 13F filing for Q4 2025, filed 17 Feb 2026.